Enpidat Tablets (Dutasteride)

Adult dose

The recommended dose is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dosage adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose in patients with hepatic impairment has not been established because there are no data on administration of this medicine to patients with hepatic impairment.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle this drug directly. In particular, avoiding contact with broken or crushed pieces of this medication is advised, as it may pose a risk of birth defects in male fetuses. Children should also be cautioned against handling this medication in broken or crushed form. This medication is not to be used by women or children under 18 years of age. Additionally, individuals with allergies to this medication or its ingredients should not use it. Adult men planning to conceive should take this medication cautiously under medical advice, as it may affect reproductive function. Patients with severe urinary retention or liver function problems should also exercise caution when taking this medication. Since this medication is metabolized in the liver, patients with liver disorders need to be careful when taking it, and caution should also be exercised when using concomitant medications that interfere with liver metabolism. During treatment with this medication, sexual side effects such as erectile dysfunction, reduced libido, and ejaculation disorders may occur, and these symptoms may continue even after discontinuation of the medication. This medication is used in the treatment of benign prostatic hyperplasia and male pattern baldness, and tests to confirm the absence of prostate cancer are necessary before and during treatment. This medication lowers serum PSA levels, so caution is needed when interpreting PSA test results. If lumps or secretions appear in the breast during treatment with this medication, it is essential to inform a physician immediately, as rare cases of male breast cancer have been reported. Blood donation should be avoided during treatment with this medication, and it is permissible only six months after the last dose. In the case of overdose, there is no specific antidote, so appropriate treatment should be administered according to the symptoms, and long-term monitoring is necessary due to the prolonged half-life of this medication. This medication should be kept out of the reach of children and stored in its original container to prevent misuse or degradation of quality. It is known that this medication does not affect the ability to drive or operate machinery; however, caution is required if any adverse reactions occur. There is a potential for interactions with other medications, so it is advisable to consult a physician, especially when taking drugs that affect liver metabolism.

• erectile dysfunction
• decreased libido
• ejaculation disorders
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a sealed container to prevent air or moisture ingress. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the efficacy and safety of the medication over time.

Appearance

Pale yellow egg-shaped film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)